ZA201804381B - Transmucosal drug delivery devices for use in chronic pain relief - Google Patents

Transmucosal drug delivery devices for use in chronic pain relief

Info

Publication number
ZA201804381B
ZA201804381B ZA2018/04381A ZA201804381A ZA201804381B ZA 201804381 B ZA201804381 B ZA 201804381B ZA 2018/04381 A ZA2018/04381 A ZA 2018/04381A ZA 201804381 A ZA201804381 A ZA 201804381A ZA 201804381 B ZA201804381 B ZA 201804381B
Authority
ZA
South Africa
Prior art keywords
drug delivery
delivery devices
chronic pain
pain relief
transmucosal drug
Prior art date
Application number
ZA2018/04381A
Other languages
English (en)
Inventor
Finn Andrew
Vasisht Niraj
Original Assignee
Biodelivery Sciences Int Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biodelivery Sciences Int Inc filed Critical Biodelivery Sciences Int Inc
Publication of ZA201804381B publication Critical patent/ZA201804381B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA2018/04381A 2011-12-21 2018-06-29 Transmucosal drug delivery devices for use in chronic pain relief ZA201804381B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161578755P 2011-12-21 2011-12-21

Publications (1)

Publication Number Publication Date
ZA201804381B true ZA201804381B (en) 2022-12-21

Family

ID=48669710

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2018/04381A ZA201804381B (en) 2011-12-21 2018-06-29 Transmucosal drug delivery devices for use in chronic pain relief

Country Status (16)

Country Link
EP (1) EP2793870A4 (zh)
JP (1) JP6255349B2 (zh)
KR (4) KR20210003313A (zh)
CN (2) CN104125828A (zh)
AU (4) AU2012358308A1 (zh)
BR (1) BR112014015329A2 (zh)
CA (1) CA2859859A1 (zh)
EA (2) EA201992762A1 (zh)
HK (1) HK1203365A1 (zh)
IL (2) IL233075A0 (zh)
IN (1) IN2014DN06117A (zh)
MX (2) MX362217B (zh)
SG (3) SG11201403075XA (zh)
UA (1) UA118540C2 (zh)
WO (1) WO2013096811A2 (zh)
ZA (1) ZA201804381B (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021163529A2 (en) * 2020-02-13 2021-08-19 Biodelivery Sciences International, Inc. Methods of treatment with buprenorphine

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5800832A (en) 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
DE19652188C2 (de) * 1996-12-16 2002-02-14 Lohmann Therapie Syst Lts Flache Arzneizubereitung zur Applikation und Freisetzung von Buprenorphin oder einer pharmakologisch vergleichbaren Substanz in der Mundhöhle und Verfahren zu ihrer Herstellung
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
DE19960154A1 (de) * 1999-12-14 2001-07-12 Lohmann Therapie Syst Lts Flache Arzneizubereitung zur transmucosalen Verabreichung von Oxycodon oder einem vergleichbaren Wirkstoff in der Mundhöhle, für die Anwendung in der Schmerztherapie und Suchttherapie
AU776904B2 (en) 2000-02-08 2004-09-23 Euro-Celtique S.A. Controlled-release compositions containing opioid agonist and antagonist
WO2002088157A1 (fr) 2001-04-27 2002-11-07 Ajinomoto Co., Inc. Derives pyrazolyl-o-glycoside n-substitues et medicament contre le diabete en contenant
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
DE102005007859A1 (de) * 2005-02-21 2006-08-24 Lts Lohmann Therapie-Systeme Ag Vefahren für eine medikamentöse Kombinations-Behandlung, sowie hierfür geeignete Arzneimittel-Kombinationen
US20060281775A1 (en) * 2005-06-14 2006-12-14 Applied Pharmacy Services, Inc. Two-component pharmaceutical composition for the treatment of pain
WO2007070632A2 (en) * 2005-12-13 2007-06-21 Biodelivery Sciences International, Inc. Abuse resistant transmucosal drug delivery device
AU2007238092A1 (en) 2006-04-12 2007-10-25 Spinalmotion, Inc. Posterior spinal device and method
AU2007275581B2 (en) * 2006-07-21 2011-09-08 Biodelivery Sciences International, Inc. Transmucosal delivery devices with enhanced uptake
EP1897543A1 (en) * 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine- wafer for drug substitution therapy
US20090270438A1 (en) * 2006-10-18 2009-10-29 Clive Booles Novel compositions and formulations
GB0620661D0 (en) * 2006-10-18 2006-11-29 Pharmasol Ltd Novel compounds
GB2447016A (en) * 2007-03-01 2008-09-03 Reckitt Benckiser Healthcare Buprenorphine/naloxone compositions
CN102056578A (zh) * 2008-06-23 2011-05-11 生物递送科学国际公司 多向粘膜给药装置及使用方法
US8475832B2 (en) 2009-08-07 2013-07-02 Rb Pharmaceuticals Limited Sublingual and buccal film compositions

Also Published As

Publication number Publication date
MX2014007350A (es) 2014-09-15
UA118540C2 (uk) 2019-02-11
SG11201403075XA (en) 2014-07-30
AU2021202042A1 (en) 2021-04-29
EP2793870A4 (en) 2016-02-17
SG10202012743WA (en) 2021-01-28
CA2859859A1 (en) 2013-06-27
EA201491046A1 (ru) 2014-11-28
IN2014DN06117A (zh) 2015-08-14
WO2013096811A3 (en) 2014-07-24
KR20140106720A (ko) 2014-09-03
SG10201710667YA (en) 2018-02-27
BR112014015329A8 (pt) 2017-06-13
KR20210003313A (ko) 2021-01-11
AU2019202602A1 (en) 2019-05-02
CN104125828A (zh) 2014-10-29
HK1203365A1 (zh) 2015-10-30
IL285091A (en) 2021-08-31
MX2021012154A (es) 2021-11-03
KR20190110628A (ko) 2019-09-30
AU2017258916A1 (en) 2017-11-30
IL233075A0 (en) 2014-07-31
AU2017258916B2 (en) 2019-01-17
KR102026321B1 (ko) 2019-09-27
BR112014015329A2 (pt) 2017-06-13
MX362217B (es) 2019-01-09
WO2013096811A2 (en) 2013-06-27
EP2793870A2 (en) 2014-10-29
JP2015500886A (ja) 2015-01-08
EA201992762A1 (ru) 2020-07-31
JP6255349B2 (ja) 2017-12-27
CN110123792A (zh) 2019-08-16
KR20220047889A (ko) 2022-04-19
AU2012358308A1 (en) 2014-07-24
EA034529B1 (ru) 2020-02-18

Similar Documents

Publication Publication Date Title
HK1200388A1 (zh) 固定劑量藥物輸送裝置
HK1198139A1 (zh) 藥物遞送醫療裝置
IL232768A0 (en) A drug delivery device
ZA201307378B (en) Medicament delivery device
GB2479953B (en) Drug delivery device
IL227712A0 (en) Device for sending medicine
HK1179542A1 (zh) 藥物遞送裝置
SG10201700715SA (en) Drug delivery device
EP2544741A4 (en) DEVICE FOR DELIVERY OF MEDICAMENT
EP2533834A4 (en) APPARATUS FOR MEDICAMENT ADMINISTRATION
EP2897598A4 (en) TRANSDERMIC DRUG DELIVERY DEVICE
ZA201302588B (en) Medicament delivery device
EP2640448A4 (en) DEVICE FOR DISTRIBUTING MEDICINE
PL2616133T3 (pl) Aparaty do podawania leków przez skórę
EP2788053A4 (en) DEVICE FOR DELIVERING MEDICAMENTS
ZA201306604B (en) Drug delivery device
EP2640449A4 (en) DEVICE FOR DISTRIBUTING MEDICINE
ZA201208185B (en) Intravaginall drug delivery device
EP2560711A4 (en) DEVICE FOR DELIVERY OF MEDICAMENT
IL285091A (en) Transmucosal drug release devices for use in chronic pain relief
IL232390A0 (en) Device for upgraded pressure treatment in small doses and drug injection
EP2706962A4 (en) SURFACE CHARACTERISTICS OF DRUG RETENTION IN AN IMPLANTABLE MEDICAL DEVICE
EP2626055A4 (en) ACTIVE RELEASE DEVICE